In addition, in humans CD69 expression is decreased in Treg cells from patients with systemic scleroderma (36) and response to tocilizumab is higher in rheumatoid arthritis patients homozygous for the mayor allele of rs11052877 (37). This evidence concerns the gene CD69 and systemic sclerosis.